The goal of this initiative is to increase our capacity for CRC screening of average-risk individuals in the screen-eligible age group in Ontario. This has been a very successful approach in Kaiser Permanente in Northern California, which has had a nurse FS program in place since 1994. PA: Is there some sensitivity about turning over a revenuegenerating procedure to nonphysicians? In other specialties such as dialysis and cardiology, much of the work is performed by nurses and technicians, with revenue going to the physicians. This has allowed those groups to devote more time to cognitive work, research and teaching. LR: This will depend on the funding model -there are several different ways in which this activity could be funded. Opportunistic screening is what we are all doing now in Canada. This is completely ad hoc. It depends on either a general practitioner or the patient raising the issue, and because this often is not mentioned during an office visit, screening does not happen. For example, we know that less than 20% of screen-eligible individuals in Ontario are screened, using any method.
Organized screening would include, at a minimum, the following:
• invitations to screen targeted at the screen-eligible population;
• information technology infrastructure to support the screening program; • timely access to screening and follow-up tests (colonoscopy);
• quality assurance (credentialing of endoscopist, measurement of colonoscopy adverse events, measurement of proportion of incomplete colonoscopies, etc); and
• tracking of clinical outcomes (CRC incidence, CRC stage, CRC mortality).
PA: If technical fees are introduced to cover the overhead costs for endoscopy, how will this change the landscape? LR: Technical fees are one way of funding endoscopic services when they are delivered in nonhospital settings, such as offices. However, we need to be clear that simply putting technical fees in place does not constitute an organized screening program. The office endoscopy environment is currently completely unregulated. Technical fees, in and of themselves, will not solve this problem. PA: Is Ontario an easier environment to try to implement an organized screening program than the United States?
LR: Any of our provinces -because we have single-payor, universal access health care systems -provide a good framework for implementation of an organized CRC screening program. In the United States, unless you are within a large system that has a single payor (such as the publicly funded Veterans Affairs Health Care System, or Kaiser Permanente, a large nonprofit health maintenance organization) this is very difficult, because health care funding is like a patchwork quilt with many payors, with different fee reimbursement structures and with differences in the services covered. In Canada, we are in an ideal position to move this forward. PA: Can you predict the future of colon cancer screening in Ontario over the next decade? LR: I believe we will begin to implement FOBT screening and that it will be phased in, adding geographical areas each year. In this way, we could have a full program implemented by year 5. We will create colonoscopy hubs for the FOBTpositive persons to be followed up. We will also see sites at which nurse-administered FS is offered as an option for the initial screening test.
